OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 3.57B KRW in the quarter ending March 31, 2026, with 265.80% growth. This brings the company's revenue in the last twelve months to 17.26B, up 193.32% year-over-year. In the year 2025, OliX Pharmaceuticals had annual revenue of 14.67B with 158.35% growth.

• Revenue (ttm): 17.26B
• Revenue Growth: +193.32%
• P/S Ratio: 144.88
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.50T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	14.67B	8.99B	158.35%
Dec 31, 2024	5.68B	-11.39B	-66.73%
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error